Dijous 11 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
El jueves 11 de Junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Thursday, Jun 11th, the Digital Repository will be unavailable due to a system update.

Document type

Article

Version

Accepted version

Publication date

All rights reserved

Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/139666

Magnetic mesoporous nanocarriers for drug delivery with improved therapeutic efficacy

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Mesoporous CoNi@Au core@shell nanorods were synthesized as magnetic drug nanocarriers by electrodeposition using ionic liquid-in-aqueous microemulsions. Mesoporous nanorods present a highly effective area (186 m2 g-1) and magnetic character that allows their manipulation, concentration and retention by applying a magnetic field. The nanorods have been functionalized with thiol-poly(ethyleneglycol) molecules and molecules of Irinotecan, a drug, used in chemotherapy, were retained in both the lattice of the linked thiol-poly(ethyleneglycol) molecules and inside the nanorods pores. The nanorods' mesoporous character allowed a high drug-loading capability and magnetic behavior that allowed the drug's controlled release. A high cellular viability of HeLa cells was obtained after their incubation with the nanorods functionalized with thiol-poly(ethyleneglycol). However, when the nanorods functioned as carriers for CPT-11, significant cell death was occurred when the HeLa cells were incubated with the functionalized, drug-loaded nanorods. Cell death also occurred by applying an alternating magnetic field, given the effect of both the carrier's CPT-11 release and the mechanical damage of cells by the nanorods under the magnetic field effect. Our proposal to used mesoporous magnetic nanorods as drug carriers could thus dramatically reduce the amounts of the nanocarrier and the drug needed to efficiently destroy cancer cells.

Subject (English)

Citation

Citation

SERRÀ I RAMOS, Albert, et al. Magnetic mesoporous nanocarriers for drug delivery with improved therapeutic efficacy. Advanced Functional Materials. 2016. Vol. 26, num. 36, pags. 6601-6611. ISSN 1616-301X. [consulted: 10 of June of 2026]. Available at: https://hdl.handle.net/2445/139666

Export metadata

JSON - METS

Share record